Membrane estrogen receptors mediate calcium signaling and MAP kinase activation in individual hippocampal neurons.
Previously we demonstrated that 17β-Estradiol (E2) induced rapid Ca(2+) influx via L-type calcium channel activation, which was required for activation of Src/ERK/CREB/Bcl2 signaling cascade and subsequent induction of neuroprotective and neurotrophic responses in rat hippocampal and cortical neurons (Wu et al., 2005; Zhao et al., 2005). The current study determined the presence and specificity of membrane E2 binding sites and the functional consequence of E2 binding to membrane receptors in individual neurons. Using E2-BSA-FITC (fluorescein isothiocyanate) macromolecular complex, membrane E2 binding sites were observed in hippocampal neurons. Punctate FITC signal was observed on plasma membrane of soma and neuronal processes in E2-BSA-FITC binding neurons. No membrane binding was observed with BSA-FITC. Specificity of binding was demonstrated by competition with excess un-conjugated E2. An ERa specific agonist, PPT, and an ERb agonist, DPN, partially competed for E2-BSA-FITC binding. Imaging of intracellular Ca(2+) ([Ca(2+)]i) in live neurons, revealed rapid Ca(2+) responses in E2-BSA-FITC binding neurons within minutes that culminated in a greater [Ca(2+)]i rise and [Ca(2+)]i spikes at >20 min. The same neurons in which E2-BSA-FITC induced a [Ca(2+)]i rise also exhibited activated pERK (extracellular signal-regulated kinase) that was translocated to the nucleus. Immunofluorescent analyses demonstrated that both excitatory and inhibitory neuronal markers labeled subpopulations of E2-BSA-FITC binding neurons. All E2-BSA-FITC binding neurons expressed L-type calcium channels. These results demonstrate, at a single cell level, that E2 membrane receptors mediate the rapid signaling cascades required for E2 neuroprotective and neurotrophic effects in hippocampal neurons. These results are discussed with respect to therapeutic targets of estrogen therapy in brain.
University of Southern California, Pharmaceutical Sciences Center, Los Angeles, CA 90089-9121, USA. tzuweiwu@mmc.edu.tw
Tzu-Wei
TW
Wu
Shuhua
S
Chen
Roberta D
RD
Brinton
D000818:Animals; D020013:Calcium Signaling / Q000502:physiology*; D002478:Cells, Cultured; D004789:Enzyme Activation / Q000502:physiology; D005260:Female; D006624:Hippocampus / Q000166:cytology / Q000378:metabolism*; D020935:MAP Kinase Signaling System / Q000502:physiology*; D008565:Membrane Proteins / Q000502:physiology*; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism*; D009474:Neurons / Q000166:cytology / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D011960:Receptors, Estrogen / Q000502:physiology*
D008565:Membrane Proteins; D011960:Receptors, Estrogen; D020928:Mitogen-Activated Protein Kinases
Endocrinology. 2008 Jul;149(7):3306-12
18356271
J Neurosci Res. 2005 Jul 1;81(1):31-7
15952176
Brain Res. 2002 May 10;935(1-2):73-80
12062475
Mol Endocrinol. 2006 Mar;20(3):491-502
16306086
Brain Res Rev. 2008 Mar;57(2):309-20
17662459
Mol Cell Biol. 2003 Mar;23(5):1633-46
12588983
Nature. 1983 Feb 10;301(5900):517-20
6130475
Mol Endocrinol. 2004 Dec;18(12):2854-65
15231873
Endocrinology. 2003 May;144(5):1812-24
12697687
Neuroscience. 2005;135(1):59-72
16084662
Eur J Neurosci. 1998 Jan;10(1):255-62
9753134
Steroids. 2002 May;67(6):429-37
11960618
Circulation. 2003 Jan 7;107(1):120-6
12515753
Endocrine. 2001 Apr;14(3):407-15
11444439
Exp Eye Res. 2006 Oct;83(4):920-31
16793038
J Comp Neurol. 2001 Nov 12;440(2):144-55
11745614
Mol Endocrinol. 2005 Aug;19(8):1951-9
15705661
Nature. 2000 Sep 28;407(6803):538-41
11029009
Endocrinology. 2003 May;144(5):2055-67
12697714
Cell. 1994 Jun 17;77(6):841-52
7911739
Neuron. 2003 Sep 11;39(6):951-60
12971895
J Med Chem. 2005 May 19;48(10):3463-6
15887952
Oncogene. 2001 Sep 6;20(39):5420-30
11571639
Mol Endocrinol. 1999 Feb;13(2):307-19
9973260
Mol Endocrinol. 2005 Jun;19(6):1606-17
15831524
Nature. 1977 Jan 6;265(5589):69-72
834244
Steroids. 2005 May-Jun;70(5-7):364-71
15862819
Brain Res Mol Brain Res. 2000 Sep 15;80(2):260-8
11038261
J Histochem Cytochem. 1985 Mar;33(3):240-8
2579123
J Neurosci. 2002 Oct 1;22(19):8391-401
12351713
Mol Endocrinol. 2005 Feb;19(2):277-89
15486047
Proc Natl Acad Sci U S A. 2004 May 4;101(18):7158-63
15103023
Endocrinology. 2002 Jan;143(1):205-12
11751611
J Neurophysiol. 1999 Feb;81(2):925-9
10036289
Mol Cell Neurosci. 1993 Feb;4(1):36-46
19912906
J Neurochem. 2003 Mar;84(6):1340-8
12614334
J Steroid Biochem Mol Biol. 2006 Feb;98(2-3):97-110
16414261
Neuroscience. 2007 Mar 2;145(1):66-79
17239543
Endocrinology. 2004 Jan;145(1):113-25
14512434
Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7093-100
11416193
Eur J Pharmacol. 2000 Jul 21;400(2-3):205-9
10988335
Endocrinology. 2001 Dec;142(12):5145-8
11713208
J Neurochem. 2003 Nov;87(3):545-50
14535938
Steroids. 2005 May-Jun;70(5-7):388-96
15862822
Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2842-7
12604781
J Steroid Biochem Mol Biol. 2005 Feb;93(2-5):319-23
15860276
Hippocampus. 2000;10(3):274-83
10902897
J Cell Biol. 1993 Nov;123(4):949-62
8227151
FASEB J. 1995 Mar;9(5):404-10
7896011
Neuroscience. 2005;132(2):299-311
15802184
FEBS Lett. 1998 Feb 6;422(3):349-53
9498814
J Comp Neurol. 2001 Jan 15;429(3):355-71
11116225
Endocrinology. 2001 May;142(5):2039-49
11316771
J Neurosci. 1996 Jun 1;16(11):3620-9
8642406
Mol Biol Cell. 2005 Jan;16(1):231-7
15496458
J Comp Neurol. 2005 Oct 17;491(2):81-95
16127691